17th December, 2018 Morning Brief

A positive opening expected today backed by positive U.S. equity futures edged up with stocks in Japan market.

U.S. stocks closed at their lowest level since April as mounting concern over the health of the global economy overshadowed positive trade developments and signs of strength from the American consumer.

🎯 News & Impact 🎯

🎯 Cadila Healthcare :
Company received U.S. FDA approval to market Albendazole tablets. This shall be manufactured at SEZ, Ahmedabad.

🎯 Solara Active Pharma Sciences :
Company's research centre at Chennai receives zero observations on Form 483 from U.S. FDA.

🎯 Larsen & Toubro: MMRDA terminates contract with joint venture of company and SCOMI Engineering for their failure to fulfill obligations. 

🎯 Wipro :
Company's arm ‘Topcoder’ gets into strategic partnership with Denmark based Saxo Bank to give digital solutions.

🎯 Future Consumer :
Company sells its stake in Amar Chitra Katha for Rs 44.4 crore.

🎯 Infosys :
Company to divest stake in CloudEndure for $15.3 million or Rs 110 crore. The company in 2015 picked up minority stake in CloudEndure for $4 million.

🎯 Vedanta :
National Green Tribunal allowed company to resume operations of copper smelter at Thoothukudi and directed the Tamil Nadu Pollution Control Board (TNPCB) to pass fresh order of renewal of consent and restoration of electricity supply for operations within 3 weeks from the date of the order.

🎯 Teva Pharma :
Company gets US FDA nod for Herzuma, biosimilar to Herceptin, for treatment of HER2.

🎯 NTPC :
Company acquired Barauni Thermal Power Station (720 MW) in district Begusarai, Bihar from Bihar State Power Generation Company Limited.

Edited by Sharp.